Glimepiride News
Effect of diabetes drugs
In a 18-month study comparing the effects of two diabetes drugs in patients with type 2 diabetes, one drug appeared to stop progression of artery narrowing, researchers reported at the American Heart Association's Scientific...
New data showed Actos prevented progression of atherosclerotic plaque volume in patients
Data expands body of evidence in high risk population using IVUS, a unique marker for coronary atherosclerosis
Expanded Labelling for Januvia Approved by European Commission
Merck Sharp & Dohme (MSD) today announced that the European Commission has approved 'Januvia' (sitagliptin) for two additional uses for patients with type 2 diabetes. This now makes sitagliptin the only dipeptidyl peptidase-4...
Novo Nordisk Reports Results From Liraglutide Study
Danish drugmaker Novo Nordisk’s final Phase III study of liraglutide, the once-daily human GLP-1 analogue for treatment of Type 2 diabetes, demonstrated favorable blood glucose control and body weight.
Pioglitazone slowed progression of carotid artery intima-media thickness compared with glimepiride
In a randomized, double-blind, comparator-controlled, multicenter trial of 462 type 2 diabetes patients.